Ventas (NYSE:VTR) Shares Break Below 200-Day Moving Average After Earnings Miss

Shares of Ventas, Inc. (NYSE:VTR) crossed below its two hundred day moving average during trading on Tuesday following a dissappointing earnings announcement. The stock has a two hundred day moving average of $86.31 and traded as low as $83.14. Ventas shares last traded at $83.2250, with a volume of 5,397,959 shares traded.

The real estate investment trust reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.98 by ($0.85). The business had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.77 billion. Ventas had a return on equity of 1.86% and a net margin of 3.86%. The firm’s revenue for the quarter was up 23.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.88 earnings per share.

Ventas Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, October 15th. Investors of record on Wednesday, September 30th were given a dividend of $0.52 per share. The ex-dividend date of this dividend was Wednesday, September 30th. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. Ventas’s dividend payout ratio is presently 385.19%.

Ventas News Roundup

Here are the key news stories impacting Ventas this week:

• Positive Sentiment: Ventas reported third-quarter revenue of approximately $1.83 billion, above the $1.77 billion consensus estimate. Growth was led by its senior-housing operating portfolio (SHOP), where higher occupancy and stronger net operating income supported results. Ventas Q3 FFO and Revenue Results
• Positive Sentiment: Management raised its 2026 normalized funds-from-operations outlook to $3.87–$3.90 per share as its investment in SHOP reaches approximately $5.2 billion. The outlook signals confidence in continued senior-housing demand, occupancy gains and operating growth. Ventas 2026 FFO Outlook
• Positive Sentiment: Analyst commentary remains broadly constructive following the results. Cantor Fitzgerald kept an “overweight” rating and still sees substantial potential upside despite lowering its price target to $95. Cantor Fitzgerald Ventas Rating
• Neutral Sentiment: The earnings call highlighted senior-housing growth and the SHOP investment strategy as key drivers, but investors will monitor whether the large investment program produces sufficient returns and supports long-term FFO growth. Ventas Q3 2026 Earnings Call Transcript
• Negative Sentiment: BNP Paribas reduced its price target to $93 from $110, while Cantor Fitzgerald cut its target from $102 to $95. Although both targets remain above the recent trading level, the reductions suggest more measured expectations. BNP Paribas Ventas Price Target
• Negative Sentiment: Ventas recently traded below its 200-day moving average, indicating technical weakness. Its valuation also remains demanding, while reported GAAP EPS was well below consensus despite the stronger FFO and revenue performance. Ventas Technical Analysis

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. Evercore set a $100.00 price target on Ventas and gave the stock an “outperform” rating in a research report on Monday, September 21st. Cantor Fitzgerald reduced their target price on Ventas from $102.00 to $95.00 and set an “overweight” rating on the stock in a research report on Thursday. Citigroup increased their price target on Ventas from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Tuesday, August 4th. The Goldman Sachs Group raised their price target on Ventas from $110.00 to $114.00 and gave the stock a “buy” rating in a report on Friday, July 24th. Finally, Wells Fargo & Company dropped their price target on Ventas from $104.00 to $96.00 and set an “overweight” rating on the stock in a research note on Monday, October 19th. Eighteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, Ventas has a consensus rating of “Moderate Buy” and an average price target of $98.59.

Hedge Funds Weigh In On Ventas

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Angeles Wealth Management LLC raised its holdings in shares of Ventas by 3.3% during the second quarter. Angeles Wealth Management LLC now owns 3,439 shares of the real estate investment trust’s stock worth $307,000 after purchasing an additional 110 shares during the last quarter. 1834 Investment Advisors Co. grew its position in Ventas by 0.8% during the 3rd quarter. 1834 Investment Advisors Co. now owns 15,149 shares of the real estate investment trust’s stock worth $1,288,000 after purchasing an additional 120 shares during the period. Versant Capital Management Inc grew its position in Ventas by 18.7% during the 3rd quarter. Versant Capital Management Inc now owns 933 shares of the real estate investment trust’s stock worth $79,000 after purchasing an additional 147 shares during the period. Sequoia Financial Advisors LLC grew its position in Ventas by 1.2% during the 1st quarter. Sequoia Financial Advisors LLC now owns 12,894 shares of the real estate investment trust’s stock worth $1,054,000 after purchasing an additional 148 shares during the period. Finally, Eastern Bank raised its stake in shares of Ventas by 5.0% during the 3rd quarter. Eastern Bank now owns 3,230 shares of the real estate investment trust’s stock valued at $275,000 after buying an additional 155 shares during the last quarter. Institutional investors and hedge funds own 94.18% of the company’s stock.

Ventas Price Performance

The firm has a market cap of $42.97 billion, a PE ratio of 21.39, a price-to-earnings-growth ratio of 3.17 and a beta of 0.72. The stock has a 50 day simple moving average of $87.30 and a two-hundred day simple moving average of $86.39. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.44 and a current ratio of 0.43.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust focused on healthcare and senior housing properties. The company owns, manages and develops a diversified portfolio of healthcare-related real estate, including senior living communities, medical office buildings, life science and innovation centers, and other properties serving healthcare providers and institutions.

Ventas generally leases its properties to healthcare operators, physicians, health systems, universities and research organizations.